Inso Biosciences

About:

Inso Bio is developing automtion tools for genomic sample handling.

Top Investors: National Science Foundation, SOSV, National Institutes of Health, New York Ventures, 2048 Ventures

Description:

Inso Biosciences is an early-stage biotechnology company developing hardware platforms and tools for genomic sample handling. Our patented microfluidic technology, invented and developed at Cornell University, performs high-efficiency processing of cellular material, and we are exploring applications in long-read DNA extraction, multiomic sample processing, and pathogen surveillance. To find out more, please visit our website: www.inso.bio To get in touch with us, please email: [email protected]

Total Funding Amount:

$2.83M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Ithaca, New York, United States

Founded Date:

2020-01-01

Contact Email:

contact(AT)inso.bio

Founders:

Adam Bisogni, Harold Craighead, Harvey Tian

Number of Employees:

1-10

Last Funding Date:

2022-10-11

IPO Status:

Private

Industries: